A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
- 3 November 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 38 (6), E1608-E1613
- https://doi.org/10.1016/s0735-1097(01)01612-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Acute and nine-month clinical outcomes after “suboptimal” coronary stentingJournal of the American College of Cardiology, 1999
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Abciximab Therapy and Unplanned Coronary Stent DeploymentCirculation, 1998
- Composition of Human Thrombus Assessed by Quantitative Colorimetric Angioscopic AnalysisCirculation, 1997
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Subacute stent thrombosis: Evolving issues and current conceptsJournal of the American College of Cardiology, 1996
- Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stentingJournal of the American College of Cardiology, 1996
- Relation of thrombotic occlusion of coronary stents to the indication for stenting, stent size, and anticoagulationThe American Journal of Cardiology, 1995
- Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.Circulation, 1991